株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

季節性インフルエンザワクチン - 現在・将来の市場参入企業

Seasonal Influenza Vaccines - Current and Future Players

発行 GlobalData 商品コード 263600
出版日 ページ情報 英文 99 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.99円で換算しております。
Back to Top
季節性インフルエンザワクチン - 現在・将来の市場参入企業 Seasonal Influenza Vaccines - Current and Future Players
出版日: 2016年11月01日 ページ情報: 英文 99 Pages
概要

当レポートでは、世界の季節性インフルエンザワクチン関連市場における既存企業および新規参入企業について分析し、市場全体の将来展望や促進・抑制要因、現在・将来の競争動向、主要企業のプロファイル(企業概要、事業展開、財務状況、SWOT分析)、市場全体と各企業の将来展望などを調査・考察しています。

第1章 目次

第2章 イントロダクション

第3章 市場の見通し

  • 世界市場
    • 予測
    • 促進・阻害要因:世界市場の課題

第4章 現在・将来の市場参入企業

  • 概要
  • 企業戦略の傾向
  • 企業プロファイル

第5章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC1068FPR

GlobalData has released its pharma report, "Seasonal Influenza Vaccines - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Seasonal Influenza Vaccines Market. The report identifies and analyses the key companies shaping and driving the global Seasonal Influenza Vaccines market. The report provides insight into the competitive Seasonal Influenza Vaccines landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Seasonal Influenza Vaccines
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of Seasonal Influenza Vaccines sector through market impact analysis, future market scenario and company analysis

Reasons to buy

  • Gain a high level view of the trends shaping and driving Seasonal Influenza Vaccines market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • What's the next big thing in the global Seasonal Influenza Vaccines market landscape? Identify, understand and capitalize

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 4

2 Introduction 5

  • 2.1 Catalyst 5
  • 2.2 Related Reports 6
  • 2.3 Upcoming Related Reports 6

3 Market Outlook 7

  • 3.1 Global Markets 7
    • 3.1.1 Forecast 7
    • 3.1.2 Drivers and Barriers - Global Issues 13

4 Current and Future Players 14

  • 4.1 Overview 14
  • 4.2 Trends in Corporate Strategy 18
  • 4.3 Company Profiles - Major Players 21
    • 4.3.1 Sanofi 21
    • 4.3.2 CSL Limited (Seqirus) 23
    • 4.3.3 GlaxoSmithKline 25
    • 4.3.4 AstraZeneca (MedImmune) 26
    • 4.3.5 Protein Sciences Corporation 29
    • 4.3.6 Mitsubishi Tanabe Pharma 31
    • 4.3.7 Novavax 32
  • 4.4 Other Companies 34
    • 4.4.1 Mylan 34
    • 4.4.2 Daiichi Sankyo 35

5 Appendix 36

  • 5.1 Bibliography 36
  • 5.2 Abbreviations 74
  • 5.3 Methodology 78
  • 5.4 Forecasting Methodology 78
    • 5.4.1 Vaccine Coverage 78
    • 5.4.2 Vaccines Included 79
    • 5.4.3 Key Launch Dates 79
    • 5.4.4 Influenza Vaccine Tender System Assumptions 80
    • 5.4.5 General Pricing Assumptions 81
    • 5.4.6 Individual Vaccine Assumptions 82
    • 5.4.7 Pricing of Pipeline Agents 90
  • 5.5 Primary Research - KOLs Interviewed for this Report 91
  • 5.6 Primary Research - Prescriber Survey 94
  • 5.7 About the Authors 95
    • 5.7.1 Analyst 95
    • 5.7.2 Therapy Area Director 95
    • 5.7.3 Epidemiologists 96
    • 5.7.4 Director of Epidemiology 97
    • 5.7.5 Global Director of Therapy Analysis and Epidemiology 97
  • 5.8 About GlobalData 98
  • 5.9 Disclaimer 98

List of Tables

  • Table 1: Global (7MM) Sales Forecasts ($m) for Seasonal Influenza Vaccines, 2015-2025 10
  • Table 2: Seasonal Influenza Vaccines Market - Drivers and Barriers, 7MM, 2015-2025 13
  • Table 3: Key Companies in the Seasonal Influenza Vaccines Market, 2016 17
  • Table 4: Sanofi's Seasonal Influenza Vaccine Portfolio Assessment, 2016 22
  • Table 5: CSL Limited's Seasonal Influenza Vaccine Portfolio Assessment, 2016 24
  • Table 6: GSK's Seasonal Influenza Vaccine Portfolio Assessment, 2016 26
  • Table 7: AstraZeneca's Seasonal Influenza Vaccine Portfolio Assessment, 2016 28
  • Table 8: Protein Sciences Corporation's Seasonal Influenza Vaccine Portfolio Assessment, 2016 30
  • Table 9: Mitsubishi's Seasonal Influenza Vaccine Portfolio Assessment, 2016 32
  • Table 10: Novavax's Seasonal Influenza Vaccine Portfolio Assessment, 2016 34
  • Table 11: Key Launch Dates 80
  • Table 12: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 94

List of Figures

  • Figure 1: Global (7MM) Sales for Seasonal Influenza Vaccines by Country, 2015 and 2025 12
  • Figure 2: Company Portfolio Gap Analysis in Seasonal Influenza Vaccines, 2015-2025 18
Back to Top